Resolving thromboinflammation in the brain after ischemic stroke?

Circulation

Volumn 133, Issue 22, 2016, Pages 2128-2131

  Kehrel, Beate E ^a   Fender, Anke C ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

blood platelets; Editorials; inflammation mediators; lipoxins; neutrophils; stroke

Indexed keywords

CYCLOOXYGENASE 2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6 RECEPTOR; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; AUTACOID;

BRAIN DAMAGE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMAN; HYPERTENSION; INFLAMMATION; PRIORITY JOURNAL; REVIEW; BRAIN; NEUTROPHIL;

BRAIN; BRAIN ISCHEMIA; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NEUTROPHILS; STROKE;

EID: 84966263537     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.022858     Document Type: Review

References (18)

1. De Meyer SF, Denorme F, Langhauser F, Geuss E, Fluri F, Kleinschnitz C, Thromboinflammation in stroke brain damage. Stroke 2016 47 1165 1172. doi: 10.1161/STROKEAHA.115.011238
2. De Ceunynck K, De Meyer SF, Vanhoorelbeke K, Unwinding the von Willebrand factor strings puzzle. Blood 2013 121 270 277. doi: 10.1182/blood-2012-07-442285
3. Zheng XL, ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med 2015 66 211 225. doi: 10.1146/annurev-med-061813-013241
4. Sonneveld MA, De Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL, Rottensteiner H, Scheiflinger F, Koudstaal PJ, Ikram MA, Leebeek FW, Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood 2015 126 2739 2746. doi: 10.1182/blood-2015-05-643338
5. Kehrel B, Wierwille S, Clemetson KJ, Anders O, Steiner M, Knight CG, Farndale RW, Okuma M, Barnes MJ, Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 1998 91 491 499
6. Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G, Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 2007 115 2323 2330. doi: 10.1161/CIRCULATIONAHA.107.691279
7. Chen K, Rondina MT, Weyrich AS, A sticky story for signal transducer and activator of transcription 3 in platelets. Circulation 2013 127 421 423. doi: 10.1161/CIRCULATIONAHA.112.155366
8. Horn M, Bertling A, Brodde MF, Müller A, Roth J, Van Aken H, Jurk K, Heilmann C, Peters G, Kehrel BE, Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa. J Thromb Haemost 2012 10 647 661. doi: 10.1111/j.1538-7836.2012.04640.x
9. Martinod K, Wagner DD, Thrombosis: tangled up in NETs. Blood 2014 123 2768 2776. doi: 10.1182/blood-2013-10-463646
10. Schauer C, Janko C, Munoz LE, Zhao Y, Kienhöfer D, Frey B, Lell M, Manger B, Rech J, Naschberger E, Holmdahl R, Krenn V, Harrer T, Jeremic I, Bilyy R, Schett G, Hoffmann M, Herrmann M, Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med 2014 20 511 517. doi: 10.1038/nm.3547
11. Ly JV, Zavala JA, Donnan GA, Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke. Expert Opin Pharmacother 2006 7 1571 1581. doi: 10.1517/14656566.7.12.1571
12. Brouns R, De Deyn PP, The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 2009 111 483 495. doi: 10.1016/j.clineuro.2009.04.001
13. 4 Receptor regulates neutrophil-platelet aggregation and attenuates cerebral inflammation: impact for therapy in cardiovascular disease. Circulation 2016 133 2169 2179. doi: 10.1161/CIRCULATIONAHA.115.020633
14. Gavins FN, Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? Trends Pharmacol Sci 2010 31 266 276. doi: 10.1016/j.tips.2010.04.001
15. Fullerton JN, Gilroy DW, Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov (March 29, 2016). doi: 10.1038/nrd.2016.39. http://www.nature.com/nrd/journal/vaop/ncurrent/full/nrd.2016.39.html
16. Romano M, Lipoxin and aspirin-triggered lipoxins. ScientificWorldJournal 2010 10 1048 1064. doi: 10.1100/tsw.2010.113
17. Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR, Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab 2015 35 888 901. doi: 10.1038/jcbfm.2015.45
18. Moriya Y, Mizuma A, Uesugi T, Ohnuki Y, Nagata E, Takahashi W, Kobayashi H, Kawada H, Ando K, Takagi S, Takizawa S, Phase I study of intravenous low-dose granulocyte colony-stimulating factor in acute and subacute ischemic stroke. J Stroke.Cerebrovasc Dis 2013 22 1088 1097. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.002